Your breath could soon replace blood tests for tracking metabolism. ETH Zurich scientists have built a handheld device — as easy to use as a police breathalyser — that detects fat-burning with lab-grade accuracy from a single breath, no needles required.
A user performs a breath measurement with the smartphone-assisted breath acetone analyzer.
(Source: Alivion)
Acetone is the by-product of fat metabolism that is exhaled via the lungs. It is made when the body burns fat instead of carbohydrates such as sugar. Researchers from ETH Zurich have developed a breath test device that can detect acetone in exhaled air with high precision. The device is very reminiscent of the alcohol breathalysers used by the police in traffic checks and can be operated reliably by non-experts in combination with a smartphone app. People can therefore monitor their fat metabolism without professional support or blood tests. This could eventually allow diets, treatments for metabolic disorders like diabetes, and ketogenic therapies used for example for epilepsy to be monitored more closely and tailored to individual patients.
“When it comes to diets, there’s no rule of thumb that works for everybody. Ideally, people should self-monitor to see how their own metabolism responds,” explains Andreas Güntner, Professor of Molecular Sensing at ETH Zurich’s Department of Mechanical and Process Engineering. “Methods are also needed that can be carried out independently and that produce reliable results, similar to blood glucose measurements for diabetics.” Güntner’s research group developed the measuring device in collaboration with the ETH spin-off Alivion, and tested its reliability together with the University Hospital Zurich.
Gallery
Precise measurements outside the lab
In a validation study involving 12 adults, the researchers compared 312 breath readings recorded with the new measuring device with blood test results and measurements from a high-precision mass spectrometer – the analytical gold standard. The measurements were carried out using different metabolic scenarios: with light and intensive physical activity and various diets. This revealed that the results from the hand-held device were practically identical to those from the lab. In addition, the new measuring device delivered reliable results over a period of months.
In essence, the recently tested hand-held device is based on a sensor technology that has been in development at ETH Zurich for over 10 years and was presented for the first time in 2017. Already at the time, Güntner and his co-authors were able to demonstrate that the gas sensors they had developed were so sensitive that they could detect a single acetone molecule in a hundred million other molecules.
Reproducible readings thanks to filter and app
According to the researchers, readings from currently available acetone breathalysers have only limited reproducibility and can only detect pronounced metabolic changes. They not only respond to acetone, but also to other components of exhaled air, for example if test subjects ate or drunk something beforehand.
The researchers therefore developed a filter that blocks interfering molecules, and a smartphone app that guides test subjects in real time as they exhale. “The device measures the volume of exhaled air and only takes a sample that comes from deep in the lungs after a certain time,” says lead author Simone Hersberger, adding: “otherwise, every reading would be slightly different.” In order for this to work, the devices are initially calibrated and adjusted to the patient’s lung volume.
The successful validation study is an important milestone for the researchers. “We were able to demonstrate that our device can detect slight differences in fat metabolism accurately and reliably,” says ETH doctoral student Hersberger. Further studies are now intended to show whether the new measuring device can really be used to personalise therapies for metabolic disorders. In partnership with the University Children’s Hospital Zurich, the researchers are currently looking at whether the hand-held device can help children with epilepsy better monitor their ketogenic diet. Other fields of application are the monitoring and optimisation of medical diets or of so-called GLP-1 therapies with weight loss jabs. Applications in amateur sports are also being considered.
Date: 08.12.2025
Naturally, we always handle your personal data responsibly. Any personal data we receive from you is processed in accordance with applicable data protection legislation. For detailed information please see our privacy policy.
Consent to the use of data for promotional purposes
I hereby consent to Vogel Communications Group GmbH & Co. KG, Max-Planck-Str. 7-9, 97082 Würzburg including any affiliated companies according to §§ 15 et seq. AktG (hereafter: Vogel Communications Group) using my e-mail address to send editorial newsletters. A list of all affiliated companies can be found here
Newsletter content may include all products and services of any companies mentioned above, including for example specialist journals and books, events and fairs as well as event-related products and services, print and digital media offers and services such as additional (editorial) newsletters, raffles, lead campaigns, market research both online and offline, specialist webportals and e-learning offers. In case my personal telephone number has also been collected, it may be used for offers of aforementioned products, for services of the companies mentioned above, and market research purposes.
Additionally, my consent also includes the processing of my email address and telephone number for data matching for marketing purposes with select advertising partners such as LinkedIn, Google, and Meta. For this, Vogel Communications Group may transmit said data in hashed form to the advertising partners who then use said data to determine whether I am also a member of the mentioned advertising partner portals. Vogel Communications Group uses this feature for the purposes of re-targeting (up-selling, cross-selling, and customer loyalty), generating so-called look-alike audiences for acquisition of new customers, and as basis for exclusion for on-going advertising campaigns. Further information can be found in section “data matching for marketing purposes”.
In case I access protected data on Internet portals of Vogel Communications Group including any affiliated companies according to §§ 15 et seq. AktG, I need to provide further data in order to register for the access to such content. In return for this free access to editorial content, my data may be used in accordance with this consent for the purposes stated here. This does not apply to data matching for marketing purposes.
Right of revocation
I understand that I can revoke my consent at will. My revocation does not change the lawfulness of data processing that was conducted based on my consent leading up to my revocation. One option to declare my revocation is to use the contact form found at https://contact.vogel.de. In case I no longer wish to receive certain newsletters, I have subscribed to, I can also click on the unsubscribe link included at the end of a newsletter. Further information regarding my right of revocation and the implementation of it as well as the consequences of my revocation can be found in the data protection declaration, section editorial newsletter.
The ETH spin-off Alivion AG has launched the device under the name ‘Nutrion’. It is currently being deployed in international research studies and in medical facilities. To scale up further and to open up further fields of application, Alivion is seeking additional industry partners and strategic investors. “This example shows how the results of basic research can be put into practice and ultimately help society,” says ETH professor Andreas Güntner.
Reference: Hersberger S, van den Broek J, Schmid L, Kappeler F, Gerber P, Güntner A. Self-monitoring of Fat Metabolic Status with Smartphone-assisted Breath Acetone Detector. Device, 22 July 2026 DOI: external page10.1016/j.device.2026.101226